[1]. Significant impact of a history of prior or concomitant upper urinary tract cancer on the recurrence and progression of non-muscle invasive bladder cancer.
Japanese journal of clinical oncology [巻]52 [号]8 [頁]944 -949 （2022年） [査読] 有
[DOI] [2]. A DNA adductome analysis revealed a reduction in the global level of C5-hydroxymethyl-2'-deoxycytidine in the non-tumoral upper urinary tract mucosa of urothelial carcinoma patients.
Genes and environment : the official journal of the Japanese Environmental Mutagen Society [巻]43 [号]1 [頁]52 （2021年） [査読] 有
[DOI] [3]. Comprehensive assessment of oncological outcomes in 186 patients with high-risk non-muscle-invasive bladder cancer: A single institution retrospective study.
Molecular and clinical oncology [巻]13 [号]3 [頁]16 （2020年） [査読] 有
[DOI] [4]. Kidney transplantation from a living donor with renal artery fibromuscular dysplasia: A case report on arterial grafting of the donor renal artery.
IJU case reports [巻]3 [号]5 [頁]201 -203 （2020年） [査読] 有
[DOI] [5]. Second transurethral resection for high-risk non-muscle invasive bladder cancer patients: a propensity score matched analysis.
Japanese journal of clinical oncology [巻]50 [号]6 [頁]718 -721 （2020年） [査読] 有
[DOI]